Stryker CorporationSYK
± MixedCapitalrelevance
Article only announces upcoming earnings date and recaps past results; no new substantive information.
Impact on stocks 1
Robotics & Physical AI
Stryker CorporationStryker Corporation will release its second quarter 2026 financial results on July 30, 2026, followed by a webcast to discuss the results. In the first quarter of 2026, net sales increased 2.6% to $6.02 billion, driven by MedSurg and Neurotechnology net sales of $3.21 billion and Orthopaedics net sales of $2.81 billion. Net earnings rose 13.9% to $0.74 billion, or $1.93 per share. For full-year 2026, the company expects organic net sales growth of 8.0% to 9.5% and adjusted net earnings per diluted share of $14.90 to $15.10. In the second quarter of 2025, consolidated net sales were $6.022 billion, with MedSurg and Neurotechnology net sales of $3.77 billion and Orthopaedics net sales of $2.25 billion.
Stryker CorporationArticle only announces upcoming earnings date and recaps past results; no new substantive information.